ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: John Kovach Succeeds Moertel As Mayo CC Head; DEA Deputy Appointed; New NCAB Member Named

February 7, 1986

ACS Executive Proposes Efficiency Plan, Critics Fear Erosion Of Local Influence

May 1, 1998

Bristol-Myers, Karolinska In Collaboration For Studies.

March 31, 2000

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011

Komen Brand Takes Hit After PR Disaster

March 30, 2012